Lower Vaginal Bleeding Research Articles

To study the current status of uterine adhesions after fetal residue and the preventive effect of using estrogen and progesterone sequential therapy combined with Foley balloon.

To investigate the current status of uterine adhesions in patients with residual fetus and analyze the preventive effect of estrogen and progesterone sequential therapy combined with Foley balloon. Eighty-six patients with residual fetus were divided into control group and observation group. On the basis of the treatment plan of the control group, the observation group received estrogen and progesterone sequential therapy combined with Floey balloon treatment. Clinical efficacy, postoperative recovery status (abdominal pain duration, vaginal bleeding duration, vaginal bleeding volume, refluid time), the incidence of intrauterine adhesions, uterine hemodynamics (uterine artery systolic maximum blood flow rate [Vmax], end diastolic blood flow rate [Vmin], resistance index [RI]), and the probability of complications were evaluated. Compared with the control group, the observation group achieved higher curative effect (P < .05); the observation group had shorter duration of abdominal pain, vaginal bleeding and refluid time, and lower vaginal bleeding (P < .05); the probability of intrauterine adhesions is lower (P < .05); before treatment, there is little difference in the levels of Vmax, Vmin, RI, and other indicators between the 2 groups (P > .05). After treatment, compared with the control group, the observation group Vmax, Vmin, and other indicators, the level was significantly lower, and the RI level was significantly higher (P < .05); the observation group had a lower probability of complications (P < .05). The likelihood of uterine adhesions after fetal remains is increased. The use of estrogen and progesterone sequential therapy in conjunction with Foley balloon therapy can improve treatment efficacy, improve uterine adhesion prevention, and promote patient recovery after surgery.

Management of the Ectopic Pregnancy Located at the Level of the Uterine Scar

The ectopic pregnancy located on an uterine scar is basically defined as implantation of the gestational sac at the level of the fibrous tissue of a uterine scar. The incidence of this pathology varies a lot, it can reach up to 1 case in 2000 ectopic pregnancies. It is expected that the incidence will increase. In the case of ectopic pregnancy, there were many therapeutic, medications or surgical (radical or conservative) options. Case report: We are presenting a prospective study conducted over a period of 26 months from July 2012 to September 2014 in Craiova Emergency County Hospital. This article reports 2 cases diagnosed with ectopic Pregnancy Located at the Level of the Uterine scar. The first case is of a 26 year old patient, 4 pregnancies, 1 birth, who came to the Gynaecology practice due to a 6 week amenorrhoea, pelvic pain, low vaginal bleeding. Following the discussion with the patient, the conservative drug therapy was initiated, namely she was given methotrexate 50 mg/m2. The patient showed no side effects after the methotrexate. The second case is of a 31 year old patient, 2 pregnancies, 1 birth, who came to the gynaecology practice due to a 4-5 week amenorrhoea, pelvic pain, vaginal bleeding. Following the discussion with the patient, the decision was made to conduct the haemostatic and evacuation uterine curettage under transrectal ultrasound control in order to minimise the risk of perforation. The uterine curettage was performed in the classic way. No complications were reported during the procedure or in the recovery period. Conclusion: Ectopic pregnancy located in the uterine trance can be successfully treated with medicine, but it is preferable that in the case of patients who still want to have a baby, the trance to be repaired by means of surgery to minimize the risks and a recurrence of this pathology.